Compound Detail
CHEMBL89598
VIGABATRIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL89598 |
| Name | VIGABATRIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PJDFLNIOAUIZSL-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
2
Targets
9
Activities
2
Assay Types
1
PK Parameters
20
Publications
14
Known Names
12
Indications
1
Mechanisms
Molecular Properties
129.2
MW (Da)
0.36
ALogP
2
HBA
2
HBD
63.3
PSA (Ų)
0.54
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Prescription |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Gamma-amino-N-butyrate transaminase inhibitor | INHIBITOR | 4-aminobutyrate aminotransferase, mitochondrial | ✓ | ✓ |
Indications
Epilepsies, Partial Epilepsy Epilepsy, Complex Partial Spasms, Infantile Spasms, Infantile Spasms, Infantile Alcoholism Amphetamine-Related Disorders Cocaine-Related Disorders Obesity Tuberous Sclerosis Tourette Syndrome
ATC Classification
N03AG04
vigabatrin
Level 1: NERVOUS SYSTEM
Level 2: ANTIEPILEPTICS
Drug Warnings
Black Box Warning
General Warning
Activity Summary
Ki 7 meas.
IC50 2 meas. best 4.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 4-aminobutyrate aminotransferase, mitochondrial CHEMBL4523258 | IC50 | 4.4 | 4.4 | 39720.0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial CHEMBL3148 | IC50 | 4.38 | 4.38 | 41210.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 0.005 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| 4-aminobutyrate aminotransferase, mitochondrial | IC50 | = | 39720.0 | nM | 4.4 | Inhibition of GABA aminotransferase in mouse brain homogenates using GABA and al... | 31084949 |
| 4-aminobutyrate aminotransferase, mitochondrial | IC50 | = | 41210.0 | nM | 4.38 | Inhibition of Rattus norvegicus (rat) brain gamma-amino butyrate aminotransferas... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22128851 | 10.1021/jm201231w | Rattus norvegicus | 27 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 10762036 | 10.1016/s0960-894x(00)00064-0 | Mus musculus | 8 |
| 33062178 | 10.1021/acsmedchemlett.9b00672 | 4-aminobutyrate aminotransferase, mitochondrial | 4 |
| 14640537 | 10.1021/jm034162s | 4-aminobutyrate aminotransferase, mitochondrial | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 22128851 | 10.1021/jm201231w | 4-aminobutyrate aminotransferase, mitochondrial | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 12238932 | 10.1021/jm020134i | 4-aminobutyrate aminotransferase, mitochondrial | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 3806611 | 10.1021/jm00385a007 | Mus musculus | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
Data from ChEMBL 36 via Core Engine